Literature DB >> 2044609

A prevalent missense mutation in Northern Europe associated with hyperphenylalaninaemia.

Y Okano1, R C Eisensmith, M Dasovich, T Wang, F Güttler, S L Woo.   

Abstract

A missense mutation has been identified in the phenylalanine hydroxylase (PAH) gene of a Danish patient with hyperphenylalaninaemia (HPA). An A-to-G transition at the second base of codon 414 results in the substitution of Cys for Tyr in the mutant PAH protein. In in vitro expression studies, the Tyr414-to-Cys414 mutant construct produced a protein which exhibited a significant amount of normal PAH enzyme activity, which is consistent with both in vitro and in vivo measurements of PAH activity in HPA patients. Population genetic studies reveal that this mutation is present on 50% of mutant haplotype 4 chromosomes in the Danish population. Together with the previously reported codon 158 mutation, these two mutant alleles comprise over 90% of all mutant haplotype 4 chromosomes in the Northern European population. Thus, two allele-specific oligonucleotide probes can detect most mutant haplotype 4 chromosomes in Northern Europe.

Entities:  

Mesh:

Year:  1991        PMID: 2044609     DOI: 10.1007/bf01955938

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  32 in total

Review 1.  Molecular basis and population genetics of phenylketonuria.

Authors:  S L Woo
Journal:  Biochemistry       Date:  1989-01-10       Impact factor: 3.162

2.  Electroporation for the efficient transfection of mammalian cells with DNA.

Authors:  G Chu; H Hayakawa; P Berg
Journal:  Nucleic Acids Res       Date:  1987-02-11       Impact factor: 16.971

3.  Hybridization of genomic DNA to oligonucleotide probes in the presence of tetramethylammonium chloride.

Authors:  A G DiLella; S L Woo
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

4.  Clinical and biochemical observations of patients with atypical phenylketonuria.

Authors:  E S Kang; S Kaufman; P S Gerald
Journal:  Pediatrics       Date:  1970-01       Impact factor: 7.124

Review 5.  The mutation and polymorphism of the human beta-globin gene and its surrounding DNA.

Authors:  S H Orkin; H H Kazazian
Journal:  Annu Rev Genet       Date:  1984       Impact factor: 16.830

6.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel; J D Roberts; R A Zakour
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

7.  In vivo residual activities of the phenylalanine hydroxylating system in phenylketonuria and variants.

Authors:  F K Trefz; K Bartholomé; H Bickel; P Lutz; H Schmidt; H W Seyberth
Journal:  J Inherit Metab Dis       Date:  1981       Impact factor: 4.982

8.  Prenatal diagnosis and carrier detection of classic phenylketonuria by gene analysis.

Authors:  S L Woo
Journal:  Pediatrics       Date:  1984-09       Impact factor: 7.124

9.  Biochemical characterization of recombinant human phenylalanine hydroxylase produced in Escherichia coli.

Authors:  F D Ledley; H E Grenett; S L Woo
Journal:  J Biol Chem       Date:  1987-02-15       Impact factor: 5.157

10.  Expression of a preproinsulin-beta-galactosidase gene fusion in mammalian cells.

Authors:  D A Nielsen; J Chou; A J MacKrell; M J Casadaban; D F Steiner
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

View more
  16 in total

Review 1.  Phenylketonuria in Britain: genetic analysis gives a historical perspective of the disorder but will it predict the future for affected individuals?

Authors:  L A Tyfield
Journal:  Mol Pathol       Date:  1997-08

2.  Three prevalent mutations in a patient with phenylalanine hydroxylase deficiency: implications for diagnosis and genetic counselling.

Authors:  P Guldberg; H L Levy; K F Henriksen; F Guttler
Journal:  J Med Genet       Date:  1996-02       Impact factor: 6.318

3.  Severity of mutation in the phenylalanine hydroxylase gene influences phenylalanine metabolism in phenylketonuria and hyperphenylalaninaemia heterozygotes.

Authors:  E Svensson; L Iselius; L Hagenfeldt
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

4.  Phenylketonuria in Spain: RFLP haplotypes and linked mutations.

Authors:  L R Desviat; B Pérez; M Ugarte
Journal:  Hum Genet       Date:  1993-10-01       Impact factor: 4.132

5.  Haplotype distribution and mutations at the PAH locus in Croatia.

Authors:  I Barić; D Mardesić; G Gjurić; V Sarnavka; B Göbel-Schreiner; U Lichter-Konecki; D S Konecki; F K Trefz
Journal:  Hum Genet       Date:  1992 Sep-Oct       Impact factor: 4.132

6.  In vivo assessment of mutations in the phenylalanine hydroxylase gene by phenylalanine loading: characterization of seven common mutations.

Authors:  P Guldberg; I Mikkelsen; K F Henriksen; H C Lou; F Güttler
Journal:  Eur J Pediatr       Date:  1995-07       Impact factor: 3.183

7.  Genetic background of clinical homogeneity of phenylketonuria in Poland.

Authors:  J Jaruzelska; R Matuszak; S Lyonnet; F Rey; J Rey; J Filipowicz; K Borski; A Munnich
Journal:  J Med Genet       Date:  1993-03       Impact factor: 6.318

8.  A missense mutation, S349P, completely inactivates phenylalanine hydroxylase in north African Jews with phenylketonuria.

Authors:  M Weinstein; R C Eisensmith; V Abadie; S Avigad; S Lyonnet; G Schwartz; A Munnich; S L Woo; Y Shiloh
Journal:  Hum Genet       Date:  1993-02       Impact factor: 4.132

9.  Discordant phenylketonuria phenotypes in one family: the relationship between genotype and clinical outcome is a function of multiple effects.

Authors:  L A Tyfield; J Zschocke; A Stephenson; F Cockburn; A Harvie; J L Bidwell; N A Wood; L P Hunt
Journal:  J Med Genet       Date:  1995-11       Impact factor: 6.318

10.  Relation between genotype and phenotype in Swedish phenylketonuria and hyperphenylalaninemia patients.

Authors:  E Svensson; U von Döbeln; R C Eisensmith; L Hagenfeldt; S L Woo
Journal:  Eur J Pediatr       Date:  1993-02       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.